Syphilis Self-testing to Expand Test Uptake Among Men Who Have Sex With Men (SST)
NCT04480749 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2022-07-25
Summary
Syphilis infection is a major global health problem, leading to substantial morbidity among key populations in low- and middle-income countries (LMICs). Men who have sex with men (MSM) are disproportionately affected by syphilis worldwide. Rates of syphilis diagnoses have been increasing amongst MSM in many countries in the last decade. A growing evidence base supporting HIV self-testing shows that self-testing kits based on the same proposed clinical pathways are feasible and reliable. The proposed study will leverage this body of evidence and apply it to syphilis self-testing.
This is a pilot study conducted in Zimbabwe. It aims to collect initial data on the feasability of implementing syphilis self-testing to establish if a large scale-RCT of this approach would be appropriate and, if so, to inform the design of this trial.
The investigators will recruit 100 MSM in Harare to join the pilot program. Participants will be recruited through two methods: in-person at MSM community-based organizations that currently operate HIV self-testing programs and online through banner advertisements that advertise HIV self-testing.
Study Arms:
Arm 1: One arm of the pilot will receive a free syphilis self-test kit (Intervention Arm) Arm 2: One arm will receive standard free facility-based syphilis testing (Control Arm).
Intervention:
In the intervention arm the investigators will provide a treponemal rapid syphilis test kit to all participants in the intervention arm of the pilot, delivered through MSM community facilitators. This is similar to existing rapid treponemal test kits that are available at many clinical facilities. Kits will be accompanied by simplified pictorial instructions on finger prick blood sample collection. Among participants in the control group, they will receive a list of local clinics that can provide free syphilis testing.
Data Collection:
For individuals in the intervention am the investigators will aim to obtain confirmation of test uptake. This will be done using either photographic confirmation sent via encrypted message on a smartphone, SMS message of a unique code or sending a unique five-digit code along with their test result to the study coordinator. The investigators will conduct cross-sectional surveys at baseline and six months later to assess sexual risk behaviours, HIV and syphilis testing experiences, and self-testing experiences. In addition to the survey data tool the investigators will conduct in-depth interviews with a small number of participants to gain additional data about their experience of syphilis self-testing.
The investigators will obtain information on linkage to care from routine clinic administrative records and by providing study participants with a unique code to be provided when attending at the facility.
Analysis:
The investigators will used mixed-methods to evaluate our pilot intervention including
The investigators will examine the proportion of individuals who undertake a syphilis test in the interventional and control arms; among those who receive a test, the proportion of individuals who receive appropriate post-testing services. The investigators will also collect qualitative data on attitudes to syphilis self-testing and quantitative data on syphilis prevalence to inform a subsequent clinical trial.
Conditions
- Syphilis
Interventions
- DIAGNOSTIC_TEST
-
Access to Facility based Syphilis Testing
List of facilities where syphilis testing can be accessed
- DIAGNOSTIC_TEST
-
Syphilis Self-Test
Rapid Treponemal Test kit
Sponsors & Collaborators
-
Biomedical Research and Training Institute, Zimbabwe
collaborator OTHER -
Pangaea Zimbabwe Aids Trust
collaborator OTHER -
London School of Hygiene and Tropical Medicine
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-10-14
- Primary Completion
- 2021-07-01
- Completion
- 2021-12-31
Countries
- Zimbabwe
Study Locations
More Related Trials
-
Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline
NCT06069141 ·Status: RECRUITING ·Phase: NA
-
Video Tool to Promote Knowledge of Syphilis as Facilitator of HIV Transmission
NCT00553111 ·Status: COMPLETED ·Phase: NA
-
CryptoART Study: Decreasing Mortality Associated With Initiation of Antiretroviral Therapy in Sub-Saharan Africa
NCT02434172 ·Status: COMPLETED
-
Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
NCT07170748 ·Status: RECRUITING
-
Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men
NCT03980223 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Patients Who Have Not Had Success With Zidovudine
NCT00001025 ·Status: COMPLETED ·Phase: PHASE2
-
Syphilis Response to Higher Penicillin Dosage: The 2.4 Versus 7.2 Study
NCT02611765 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
NCT00002334 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin
NCT00001989 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM
NCT03608774 ·Status: COMPLETED ·Phase: PHASE4
-
The SwissPrEPared Study
NCT03893188 ·Status: RECRUITING
-
A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
NCT00002097 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
NCT00001032 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence of Histoplasmosis in HIV + Patients with a Rapid Diagnostic Test in West Indies
NCT01884779 ·Status: COMPLETED
-
Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients
NCT05523739 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection
NCT00002117 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Z-100 in Patients With Early HIV Infection
NCT00016692 ·Status: TERMINATED ·Phase: PHASE1
-
The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease
NCT00002001 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis
NCT00002316 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics
NCT01632995 ·Status: COMPLETED ·Phase: NA
-
Depot Disulfiram for AIDS and ARC
NCT00002065 ·Status: COMPLETED ·Phase: NA
-
A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
NCT00001081 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex
NCT00001011 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
NCT05814432 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus
NCT00000993 ·Status: COMPLETED ·Phase: NA